SBC Medical Group (NASDAQ:SBC) CEO Sells $1,404,300.00 in Stock

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) CEO Yoshiyuki Aikawa sold 465,000 shares of the firm’s stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $3.02, for a total transaction of $1,404,300.00. Following the completion of the sale, the chief executive officer owned 78,839,460 shares in the company, valued at $238,095,169.20. The trade was a 0.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Yoshiyuki Aikawa also recently made the following trade(s):

• On Tuesday, April 21st, Yoshiyuki Aikawa sold 3,100,000 shares of SBC Medical Group stock. The shares were sold at an average price of $3.02, for a total transaction of $9,362,000.00.
• On Friday, March 6th, Yoshiyuki Aikawa sold 4,422,900 shares of SBC Medical Group stock. The stock was sold at an average price of $2.12, for a total value of $9,376,548.00.

SBC Medical Group Price Performance

Shares of NASDAQ SBC opened at $3.31 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 3.74 and a current ratio of 3.78. SBC Medical Group Holdings Incorporated has a fifty-two week low of $2.97 and a fifty-two week high of $5.75. The firm has a market capitalization of $339.54 million, a PE ratio of 6.76 and a beta of 0.61. The stock’s 50-day simple moving average is $3.89 and its 200-day simple moving average is $3.99.

SBC Medical Group (NASDAQ:SBC) last issued its earnings results on Friday, March 27th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.01. SBC Medical Group had a return on equity of 20.76% and a net margin of 29.37%.The business had revenue of $39.57 million for the quarter, compared to analyst estimates of $45.19 million. As a group, equities research analysts forecast that SBC Medical Group Holdings Incorporated will post 0.47 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of SBC. Geode Capital Management LLC acquired a new position in shares of SBC Medical Group in the second quarter valued at approximately $455,000. Millennium Management LLC acquired a new position in shares of SBC Medical Group during the third quarter worth about $219,000. New York State Common Retirement Fund acquired a new position in shares of SBC Medical Group during the second quarter worth about $104,000. Williams & Novak LLC acquired a new position in shares of SBC Medical Group during the fourth quarter worth about $65,000. Finally, XTX Topco Ltd acquired a new position in shares of SBC Medical Group during the second quarter worth about $64,000. Institutional investors and hedge funds own 60.82% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on SBC. BTIG Research began coverage on SBC Medical Group in a research report on Friday, March 6th. They set a “buy” rating and a $8.00 price target on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of SBC Medical Group in a research note on Friday, March 27th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $8.50.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.